semaglutide shortage update As of February 21, 2025, the FDA updated its drug list, marking the injection shortage as resolved. Semaglutide injections are no longer classified as “currently in shortage,” and both 503A Semaglutide and Tirzepatide No Longer

These findings do not mean the medications are unsafe, but they highlight the importance of: Medical supervision Balanced nutrition Strength training Long-term treatment planning If you are exploring long-term weight loss solutions, the team at BASS Bariatric Surgery Center can help you understand whether bariatric surgery may be the right option for you

When weight loss doesnt respond to typical lifestyle strategies, its often because deeper metabolic or hormonal factors are involved

Semaglutide GLP-1 injections contain a peptide very similar to glucagon, a hormone that we naturally produce to help lower our blood sugar after eating by stimulating insulin release and blocking the production of sugar

44 , 1021 (1996) T